SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-19-024867
Filing Date
2019-04-17
Accepted
2019-04-17 09:33:27
Documents
2
Period of Report
2019-04-15

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1599
2 POA DOCUMENT poa.txt EX-24.3_847963 2977
  Complete submission text file 0001209191-19-024867.txt   6013
Mailing Address ONE NEWTON EXECUTIVE PARK SUITE 202 NEWTON MA 02462
Business Address ONE NEWTON EXECUTIVE PARK SUITE 202 NEWTON MA 02462 617-467-4577
Allena Pharmaceuticals, Inc. (Issuer) CIK: 0001624658 (see all company filings)

IRS No.: 452729920 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O ALLENA PHARMACEUTIALS, INC. ONEW NEWTON EXECUTIVE PARK SUITE 202 NEWTON MA 02462
Business Address
Diaz Allene M. (Reporting) CIK: 0001773314 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38268 | Film No.: 19752328